Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Randomized study to evaluate the efficacy and safety of nafamostat mesilate use during continuous renal replacement therapy in acute kidney injury patients at a high risk of bleeding.
Epistemonikos ID: 5d0a748dd2c8e9d7dc9a44a42a16ac2e07ff6cb7
First added on: May 12, 2024